NDATOPICALCREAM
Approved
Nov 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
PSORCON (diflorasone diacetate) by PharmaIN is the mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. First approved in 1992.
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PSORCON (diflorasone diacetate) is a potent topical corticosteroid cream approved for inflammatory skin conditions. It works through anti-inflammatory mechanisms that correlate with vasoconstrictor potency, though the exact mechanism remains unclear. The drug is administered topically for dermatological indications.
LOE Approaching
As LOE approaches, the brand team is likely contracting; expect focus on generic transition planning and retention of core commercial functions.
Mechanism of Action
The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PSORCON roles are declining as the product approaches loss of exclusivity. Career opportunities are concentrated in transition management, generic preparation, and cost-containment strategies rather than growth initiatives. Positions on this brand offer valuable experience in LOE management but limited upside growth potential.
Brand Manager
Worked on PSORCON at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.